MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 44 filers reported holding MIRATI THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,390,188 | +28.8% | 3,544,311 | +6.8% | 0.00% | +33.3% |
| Q2 2023 | $119,880,026 | -0.4% | 3,318,019 | +2.5% | 0.00% | -25.0% |
| Q1 2023 | $120,347,162 | -0.3% | 3,236,879 | +21.6% | 0.00% | 0.0% |
| Q4 2022 | $120,656,994 | -28.8% | 2,662,922 | +9.7% | 0.00% | -33.3% |
| Q3 2022 | $169,555,000 | +4.8% | 2,427,751 | +0.7% | 0.01% | +20.0% |
| Q2 2022 | $161,807,000 | -29.7% | 2,410,366 | -13.8% | 0.01% | -16.7% |
| Q1 2022 | $230,022,000 | -43.1% | 2,797,638 | +1.5% | 0.01% | -40.0% |
| Q4 2021 | $404,379,000 | -14.0% | 2,756,675 | +3.7% | 0.01% | -23.1% |
| Q3 2021 | $470,265,000 | -3.8% | 2,658,210 | -12.2% | 0.01% | -7.1% |
| Q2 2021 | $489,034,000 | -37.6% | 3,027,505 | -33.8% | 0.01% | -39.1% |
| Q1 2021 | $783,456,000 | -16.7% | 4,573,591 | +6.8% | 0.02% | -23.3% |
| Q4 2020 | $940,151,000 | +66.0% | 4,280,412 | +25.5% | 0.03% | +42.9% |
| Q3 2020 | $566,377,000 | +43.9% | 3,410,886 | -1.1% | 0.02% | +31.2% |
| Q2 2020 | $393,617,000 | +72.1% | 3,447,637 | +15.8% | 0.02% | +45.5% |
| Q1 2020 | $228,778,000 | -35.6% | 2,976,170 | +8.0% | 0.01% | -21.4% |
| Q4 2019 | $355,228,000 | +66.8% | 2,756,699 | +0.9% | 0.01% | +55.6% |
| Q3 2019 | $212,949,000 | -18.5% | 2,733,270 | +7.8% | 0.01% | -18.2% |
| Q2 2019 | $261,211,000 | +52.5% | 2,536,034 | +8.6% | 0.01% | +37.5% |
| Q1 2019 | $171,236,000 | +96.6% | 2,336,095 | +13.8% | 0.01% | +100.0% |
| Q4 2018 | $87,086,000 | +17.1% | 2,052,949 | +30.0% | 0.00% | +33.3% |
| Q3 2018 | $74,364,000 | +3.9% | 1,578,852 | +8.8% | 0.00% | 0.0% |
| Q2 2018 | $71,544,000 | +267.4% | 1,451,214 | +128.8% | 0.00% | +200.0% |
| Q1 2018 | $19,472,000 | +109.1% | 634,234 | +24.3% | 0.00% | – |
| Q4 2017 | $9,314,000 | +145.7% | 510,362 | +57.5% | 0.00% | – |
| Q3 2017 | $3,791,000 | +247.8% | 323,943 | +8.4% | 0.00% | – |
| Q2 2017 | $1,090,000 | -76.3% | 298,849 | -66.3% | 0.00% | – |
| Q1 2017 | $4,606,000 | +24142.1% | 885,598 | +22613.5% | 0.00% | – |
| Q4 2016 | $19,000 | -29.6% | 3,899 | -4.1% | 0.00% | – |
| Q3 2016 | $27,000 | +22.7% | 4,065 | 0.0% | 0.00% | – |
| Q2 2016 | $22,000 | +46.7% | 4,065 | +458.4% | 0.00% | – |
| Q1 2016 | $15,000 | +36.4% | 728 | +118.0% | 0.00% | – |
| Q4 2015 | $11,000 | +83.3% | 334 | +81.5% | 0.00% | – |
| Q3 2015 | $6,000 | 0.0% | 184 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | -14.3% | 184 | -22.7% | 0.00% | – |
| Q1 2015 | $7,000 | – | 238 | +1152.6% | 0.00% | – |
| Q1 2014 | $0 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |